Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma

NCT00483301 is registered in ClinicalTrials.gov with Mt. Sinai Medical Center, Miami as lead sponsor.

NCT NCT00483301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00483301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma
Lead sponsor
Mt. Sinai Medical Center, Miami
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
August 31, 2009
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma